Dec 07, 2022
573:500
For every 500 shares held, investors received 573. The price per share adjusted from $0.69 to $0.60.
The split itself did not change the total investment value.
Biocartis Group N.V. (BIOGF) trades on the Other OTC in the Medical - Diagnostics & Research industry.
Biocartis Group N.V. company overviewThe latest split shown was on December 7, 2022. It was a 573-for-500 forward split, so shareholders received 573 shares for every 500 they held.
This history records one forward split, on December 7, 2022.
Already premium? Sign in